|
Volumn 17, Issue 2, 2008, Pages 68-69
|
A stunning day in hypertension research - Results of ONTARGET, ACCOMPLISH and HYVET
a a a a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ACETYLSALICYLIC ACID;
AMLODIPINE PLUS BENAZEPRIL;
ANGIOTENSIN RECEPTOR ANTAGONIST;
BENAZEPRIL PLUS HYDROCHLOROTHIAZIDE;
BETA ADRENERGIC RECEPTOR BLOCKING AGENT;
CALCIUM CHANNEL BLOCKING AGENT;
DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;
DIURETIC AGENT;
HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;
INDAPAMIDE;
PERINDOPRIL;
PLACEBO;
RAMIPRIL;
TELMISARTAN;
THIAZIDE DIURETIC AGENT;
BLOOD PRESSURE MEASUREMENT;
CARDIOVASCULAR RISK;
CLINICAL RESEARCH;
CLINICAL TRIAL;
COMBINATION CHEMOTHERAPY;
DIABETES MELLITUS;
DRUG EFFICACY;
DRUG RESPONSE;
DRUG TOLERABILITY;
EDITORIAL;
ELDERLY CARE;
HIGH RISK POPULATION;
HUMAN;
HYPERTENSION;
KIDNEY FUNCTION;
MONOTHERAPY;
PRIORITY JOURNAL;
RISK REDUCTION;
UNSPECIFIED SIDE EFFECT;
AMLODIPINE;
ANTIHYPERTENSIVE AGENTS;
BENZAZEPINES;
BENZIMIDAZOLES;
BENZOATES;
CLINICAL TRIALS AS TOPIC;
DRUG THERAPY, COMBINATION;
HUMANS;
HYPERTENSION;
INDAPAMIDE;
PERINDOPRIL;
RAMIPRIL;
|
EID: 45949095063
PISSN: 08037051
EISSN: 16511999
Source Type: Journal
DOI: 10.1080/08037050802117791 Document Type: Editorial |
Times cited : (4)
|
References (6)
|